Hillmann Laboratories, headquartered in Singapore, is advancing the development of an Ebola vaccine recognised by the World Health Organisation (WHO) as the leading candidate to help control the spread of the virus in the Democratic Republic of Congo (DRC). The company announced plans to fast-track. .



